Perrigo Company is acquiring HRA Pharma, a manufacturer of health care products. The purchase will allow Perrigo to increase revenues and EPS for fiscal year 2023 by €400 million and $1, respectively. The deal is valued at €1.8 billion and is expected to close in mid-2022.